Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea

Journal of Bone and Mineral Metabolism
Dong Won ByunYong-Ki Min

Abstract

Patient-reported outcomes (PROs) provide practical guides for treatment; however, studies that have evaluated PROs of women in Korea with postmenopausal osteoporosis (PMO) are lacking. This cross-sectional, multi-center (29 nationwide hospitals) study, performed from March 2013 to July 2014, aimed to assess PROs related to treatment satisfaction, medication adherence, and quality of life (QoL) in Korean PMO women using osteoporosis medication for prevention/treatment. Patient demographics, clinical characteristics, treatment patterns, PROs, and experience using medication were collected. The 14-item Treatment Satisfaction Questionnaire for Medication (TSQM) (score-range, 0-100; domains: effectiveness, side effects, convenience, global satisfaction), Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS) (score-range, 0-8), and EuroQol-5 dimensions questionnaire (index score range, - 0.22 to 1.0; EuroQol visual analog scale score range, 0-100) were used. To investigate factors associated with PROs, linear (treatment satisfaction/QoL) or logistic (medication adherence) regression analyses were conducted. A total of 1804 patients (age, 62 years) were investigated; 60.1% used bisphosphonate, with the majority (67.2%) us...Continue Reading

References

Mar 13, 2002·Annals of Periodontology·J Wactawski-Wende
Aug 31, 2002·Endocrine Reviews·Ann CranneyUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Sep 25, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Robert A YoodEva Lydick
May 29, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J Jaime CaroChristel Naujoks
Mar 10, 2005·Dental Clinics of North America·Roseann Mulligan, Stephen Sobel
May 6, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Veena DhillonGeorge Nuki
Aug 12, 2005·The New England Journal of Medicine·Clifford J Rosen
Aug 10, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A J CarrC Cooper
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Dennis M BlackUNKNOWN FLEX Research Group
Feb 27, 2007·Journal of Bone and Mineral Metabolism·Ellewellyn G PasionDaniel Thiebaud
Mar 14, 2007·The American Journal of Medicine·M Alan BrookhartDaniel H Solmon
Jan 5, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J M ValderasJ Alonso
Jun 11, 2008·American Journal of Preventive Medicine·Julie RobitailleMuin J Khoury
May 5, 2009·Current Opinion in Rheumatology·Amy H Warriner, Jeffrey R Curtis
Jun 30, 2009·The American Journal of Medicine·Nilay D ShahVéronique L Roger
Aug 8, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yeon-Kyeng LeeYoung-Tack Kim
May 7, 2010·The Journal of Clinical Endocrinology and Metabolism·Amanda R PatrickDaniel H Solomon
May 18, 2011·Epilepsy & Behavior : E&B·Waleed M SweilehDonald E Morisky
Jun 1, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·E Barrett-ConnorD Macarios
Aug 24, 2011·Journal of Korean Medical Science·Hyun-Koo YoonYong-Chan Ha
Nov 2, 2011·The Journal of the American Dental Association·John W HellsteinUNKNOWN American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents
Nov 28, 2012·Clinics·Melisa M MadureiraRosa M R Pereira
Mar 8, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Kristi ReynoldsCynthia D O'Malley
Apr 8, 2015·Clinical Interventions in Aging·Luiz Francisco BaccaroAarão Mendes Pinto-Neto
Apr 8, 2016·Expert Opinion on Pharmacotherapy·Luigi GennariDaniela Merlotti
Aug 2, 2016·Archives of Medical Science : AMS·Grażyna BączykKrystyna Jaracz
Dec 10, 2016·Digestive Diseases and Sciences·Selena Z KuoJennifer C Lai
Dec 13, 2016·JAMA : the Journal of the American Medical Association·Nelson B Watts, JoAnn E Manson
Aug 9, 2017·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N MiyakoshiY Shimada
Sep 13, 2017·Journal of Evaluation in Clinical Practice·Zoltán VokóZoltán Kaló

❮ Previous
Next ❯

Citations

Jun 16, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Young Shil ParkKi Young Yoo
Jul 27, 2021·Experimental Biology and Medicine·Ying ZhouYang Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.